19:45 IST
BSE
Annual Report
Speciality Medicines Annual Report
Speciality Medicines Limited has submitted its Annual Report for the financial year 2025-26 to the exchange, complying with regulatory filing requirements.
Speciality Medicines Ltd
- Share price
- ₹162.20
- Market cap
- ₹142.5 Cr
- Revenue (annual)
- ₹75.29 Cr
- Net profit (annual)
- ₹13.03 Cr
- P/E (TTM)
- 10.9×Sector 50.4×
- Promoter holding
- 43.43%
- FII holding
- 0.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
15:50 IST
BSE
Annual General Meeting
Speciality Medicines Annual General Meeting
Speciality Medicines Limited scheduled its 5th Annual General Meeting for September 28, 2026. The board also approved the draft Directors' Report for FY 2025-26.
17:08 IST
BSE
Financial Results
Speciality Medicines H2 FY26 Results: Net Profit ₹8.2 Cr, Up 203.7% YoY
Speciality Medicines Ltd reported revenue from operations of ₹44.8 Cr (+45.5% YoY) and net profit of ₹8.2 Cr (+203.7% YoY) for H2 FY26.
- Key figure
- Net profit ₹8.2 Cr · +203.7% YoY